Astrana Health (NASDAQ:ASTH) PT Lowered to $45.00

Astrana Health (NASDAQ:ASTH) had its price objective dropped by analysts at Stifel Nicolaus from $50.00 to $45.00 in a research report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 15.24% from the company’s previous close.

Other research analysts also recently issued research reports about the company. Truist Financial lifted their price target on Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a report on Friday, March 1st. Jefferies Financial Group started coverage on Astrana Health in a research note on Monday, February 26th. They set a “buy” rating and a $50.00 price target for the company.

Astrana Health Price Performance

Shares of ASTH opened at $39.05 on Wednesday. The firm has a market cap of $2.19 billion, a PE ratio of 29.58, a P/E/G ratio of 1.20 and a beta of 1.12. Astrana Health has a 12-month low of $28.86 and a 12-month high of $45.71. The stock has a 50 day simple moving average of $40.12. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.11 and a quick ratio of 2.11.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.31 earnings per share for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.01). Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The company had revenue of $404.36 million during the quarter, compared to analysts’ expectations of $413.84 million. During the same period in the prior year, the business posted $0.42 EPS. The company’s revenue for the quarter was up 19.9% compared to the same quarter last year. As a group, equities research analysts forecast that Astrana Health will post 1.65 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.